I. Amarante, C. Faustino, B. Mota, M. Cascais, J. Almeida, and M. Valentim, “Full recovery over one year of the overlap syndrome scleromyositis to maintenance therapy with mycophenolate mofetil and rituximab, which relapsed within 8 months of discontinuation”, EJCRIM, vol. 12, no. 5, May 2025, doi: 10.12890/2025_005154.